TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Abera Bioscience AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
238
|
0
|
116 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-1,507
|
-1,742
|
-896 |
EBITDA |
-1,514
|
-1,743
|
-896 |
Total assets |
843
|
1,759
|
3,068 |
Current assets |
670
|
1,589
|
1,216 |
Current liabilities |
333
|
251
|
217 |
Equity capital |
510
|
1,508
|
2,851 |
- share capital |
104
|
93
|
82 |
Employees (average) |
6
![]() |
6
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.5%
|
85.7%
|
92.9% |
Turnover per employee |
40
|
0
|
23 |
Profit as a percentage of turnover | -633.2% | -772.4% | |
Return on assets (ROA) |
-178.8%
|
-99.0%
|
-29.2% |
Current ratio |
201.2%
|
633.1%
|
560.4% |
Return on equity (ROE) |
-295.5%
|
-115.5%
|
-31.4% |
Change turnover |
238
|
-107
|
116 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
20%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.